Eyevance Pharmaceuticals Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 74

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 5

  • Investments
  • 3

Eyevance Pharmaceuticals General Information

Description

Manufacturer of ophthalmic pharmaceutical products intended to serve patients, healthcare providers, and pharmaceutical distributors. The company offers prescription eye drops and topical ophthalmic formulations for the treatment of eye conditions, thereby enabling regulated distribution of ophthalmic medications for clinical use.

Contact Information

Website
www.eyevance.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 777 Taylor Street
  • Suite 1050
  • Fort Worth, TX 76102
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Santen Pharmaceutical
Vertical(s)
Manufacturing
Corporate Office
  • 777 Taylor Street
  • Suite 1050
  • Fort Worth, TX 76102
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eyevance Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eyevance Pharmaceuticals‘s full profile, request access.

Request a free trial

Eyevance Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of ophthalmic pharmaceutical products intended to serve patients, healthcare providers, and pharmaceutical
Pharmaceuticals
Fort Worth, TX
74 As of 2020

Vienna, Austria
 

Watertown, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eyevance Pharmaceuticals Competitors (15)

One of Eyevance Pharmaceuticals’s 15 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
EyePoint Corporation Watertown, MA
Genentech Formerly VC-backed South San Francisco, CA
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA
Novartis Corporation Basel, Switzerland
You’re viewing 5 of 15 competitors. Get the full list »

Eyevance Pharmaceuticals Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Eyevance Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020046950-A1 Ocular lubricant formulations Inactive 30-Aug-2018

Eyevance Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eyevance Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eyevance Pharmaceuticals‘s full profile, request access.

Request a free trial

Eyevance Pharmaceuticals Investments (3)

Eyevance Pharmaceuticals’s most recent deal was a Buyout/LBO with Novartis (Tobradex ST and Natacyn). The deal was made on 16-Oct-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novartis (Tobradex ST and Natacyn) 16-Oct-2019 Buyout/LBO Buildings and Property
Novartis (FLAREX Brand) 24-Oct-2018 Corporate Asset Purchase Buildings and Property
FreshKote 11-Sep-2018 Corporate Asset Purchase Buildings and Property
To view Eyevance Pharmaceuticals’s complete investments history, request access »

Eyevance Pharmaceuticals FAQs

  • When was Eyevance Pharmaceuticals founded?

    Eyevance Pharmaceuticals was founded in 2017.

  • Where is Eyevance Pharmaceuticals headquartered?

    Eyevance Pharmaceuticals is headquartered in Fort Worth, TX.

  • What is the size of Eyevance Pharmaceuticals?

    Eyevance Pharmaceuticals has 74 total employees.

  • What industry is Eyevance Pharmaceuticals in?

    Eyevance Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Eyevance Pharmaceuticals a private or public company?

    Eyevance Pharmaceuticals is a Private company.

  • What is Eyevance Pharmaceuticals’s current revenue?

    The current revenue for Eyevance Pharmaceuticals is .

  • How much funding has Eyevance Pharmaceuticals raised over time?

    Eyevance Pharmaceuticals has raised $30M.

  • Who are Eyevance Pharmaceuticals’s investors?

    Avego Management and Hayfin Capital Management have invested in Eyevance Pharmaceuticals.

  • Who are Eyevance Pharmaceuticals’s competitors?

    Pfizer (Vienna), EyePoint, Genentech, BioMarin Pharmaceutical, and Novartis are some of the 15 competitors of Eyevance Pharmaceuticals.

  • When was Eyevance Pharmaceuticals acquired?

    Eyevance Pharmaceuticals was acquired on 27-Aug-2021.

  • Who acquired Eyevance Pharmaceuticals?

    Eyevance Pharmaceuticals was acquired by Santen Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process